In 2017 articles and early 2018 articles I indicated I was of the opinion Hormel's (HRL) shares were undervalued. In my August 28, 2018 article I indicated I viewed them as fairly valued. On November 20th, HRL released its Q4 and FY2018 results and FY2019 projections. I now view HRL shares as overvalued. Summary HRL [...]
Goldman Sachs' (GS) share price has taken a severe pounding subsequent to the revelation of the Malaysia 1MDB corruption scandal. I strongly suspect GS's stock price will experience some volatility in the short-term but the shares appear to be attractively valued to the extent where I am prepared to initiate a position for the FFJ [...]
Summary A former GS banker has pleaded guilty for his role in the Malaysia's 1MDB corruption scandal. Malaysia is seeking a full refund of the almost $0.6B that it paid to GS for three bond deals. Claims of embezzlement and money laundering have led to investigations in the U.S., Singapore, and Switzerland. GS has not [...]
I periodically employ a conservative 'out of the money covered call' option strategy when I think I can generate some option premium income and I have a strong probability of retaining the underlying security. On occasion I will employ a conservative ‘out of the money covered call’ option strategy if I think I can generate [...]
BCE, Rogers, and Telus are Canada's 3 largest publicly traded telecommunications companies. All three are solid long-term investments for investors seeking a lower level of volatility. Each company, however, has a different dividend policy which will likely influence an investor's investment decision. This article compares each company's dividend policy. Summary BCE, Rogers Communications, and [...]
On November 8, 2018 Brookfield Asset Management (BAM) released Q3 and YTD2018 results. $1.1B of Funds from Operations (FFO) were generated during Q3 versus $0.8B in Q3 2017. It has raised $12B of capital since the end of Q2 and it is now in the midst of raising capital across all three flagship funds. It [...]
Summary Becton Dickinson released its Q4 and FY2018 results and FY2019 Guidance on November 6th. Integration of Carefusion and C.R. Bard is proceeding as planned and management expects strong underlying growth of approximately 16% - 17% on a currency-neutral basis which is in excess of the C.R. Bard deal model. BDX expects to deliver adjusted [...]
On November 6, 2018 Becton Dickinson (BDX) released Q4 and FY2018 results and provided guidance for FY2019. BDX is making good progress with the integration of Carefusion and C.R. Bard. Management is committed to deleveraging the Balance Sheet to below 3x over 3 years and $1.2B of debt was repaid in FY2018 which is slightly [...]
On November 6, 2018 Broadridge (BR) released Q1 2019 results and reaffirmed FY2019 guidance which it has provided at the time of its release of FY2018 financials on August 7, 2018. In my previous BR article I viewed shares as expensive and suggested investors patiently for a better entry point. Following the release of Q1 [...]
Summary BR shares dropped ~9.7% upon the November 6, 2018 release of good Q1 2019 results and the reaffirmation of encouraging FY2019 projections. In my August 7th article I indicated I was of the opinion that BR shares were overvalued and that investors should wait for BR shares to pullback. BR’s FY2017 – FY2020 growth [...]
